Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Hart

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
BMJ Neurology Open|January 9, 2026
Prospective assessment of serum neurofilament light chain in platinum-induced and taxane-induced peripheral neuropathyDuncan Smyth, Ryan Y S Keh, Stephen Keddie, et al.
Viruses|January 26, 2024
Peripheral Neuropathy in Virologically Suppressed People Living with HIV: Evidence from the PIVOT TrialAnna L Schuldt, Henry Bern, Melanie Hart, et al.
BMC Musculoskeletal Disorders|July 21, 2017
Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trialHarindu Wijesinghe, Priyadharshini Galappatthy, Rajiva de Silva, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2014
Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infectionEmma E Page, Louise Greathead, Rebecca Metcalf, et al.
Journal of Neurology|February 22, 2025
GAD antibodies in neurological disease: a critical evaluation of the utility and treatment implications of GAD antibodies in clinical practiceRachel L Brown, Gilbert Thomas-Black, Hector Garcia-Moreno, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 30, 2023
NMDA Receptor Antibodies and Neuropsychiatric Symptoms in Parkinson's DiseaseLucy L Gibson, Thomas A Pollak, Melanie Hart, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 18, 2021
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassaysAshvini Keshavan, Henrietta Wellington, Zhongbo Chen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 1, 2020
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassaysAshvini Keshavan, Henrietta Wellington, Zhongbo Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2026
The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PETAshvini Keshavan, Katharine Wiltshire, Ryan Wee, et al.
Blood|May 31, 2013
Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signalingHugues de Lavallade, Ahmad Khoder, Melanie Hart, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
BMJ Neurology Open|January 9, 2026
Prospective assessment of serum neurofilament light chain in platinum-induced and taxane-induced peripheral neuropathyDuncan Smyth, Ryan Y S Keh, Stephen Keddie, et al.
Viruses|January 26, 2024
Peripheral Neuropathy in Virologically Suppressed People Living with HIV: Evidence from the PIVOT TrialAnna L Schuldt, Henry Bern, Melanie Hart, et al.
BMC Musculoskeletal Disorders|July 21, 2017
Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trialHarindu Wijesinghe, Priyadharshini Galappatthy, Rajiva de Silva, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2014
Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infectionEmma E Page, Louise Greathead, Rebecca Metcalf, et al.
Journal of Neurology|February 22, 2025
GAD antibodies in neurological disease: a critical evaluation of the utility and treatment implications of GAD antibodies in clinical practiceRachel L Brown, Gilbert Thomas-Black, Hector Garcia-Moreno, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 30, 2023
NMDA Receptor Antibodies and Neuropsychiatric Symptoms in Parkinson's DiseaseLucy L Gibson, Thomas A Pollak, Melanie Hart, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 18, 2021
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassaysAshvini Keshavan, Henrietta Wellington, Zhongbo Chen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 1, 2020
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassaysAshvini Keshavan, Henrietta Wellington, Zhongbo Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2026
The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PETAshvini Keshavan, Katharine Wiltshire, Ryan Wee, et al.
Blood|May 31, 2013
Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signalingHugues de Lavallade, Ahmad Khoder, Melanie Hart, et al.
Pageof 3